patients with arteriosclerotic peripheral arterial disease, Buerger'
Conditions
Interventions
LIPUS treatment
LIPUS untreated (control)
Sponsors
Hiroshima University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with critical limb ischemia
Exclusion criteria
Exclusion criteria: Patients with cancer Patients with stroke and/or myocardial infarction within 12 weeks of the prior to study Patients with heart failure (≥NYHA4)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| flow-mediated vasodilation (FMD) | — |
Secondary
| Measure | Time frame |
|---|---|
| ABPI, PWV Clinical symptoms and visual analog score Safty | — |
Countries
Japan
Contacts
Public ContactYukihito Higashi
Hiroshima university Hospital Division of Regenerative Medicine
Outcome results
None listed